Addus HomeCare Corporation (ADUS) P/E Ratio History
UndervaluedTrading at 21.9x vs 5Y avg 27.5x · 15th percentile · Below historical baseline · Data 2009–2026
Loading P/E history...
P/E Ratio Analysis
As of September 23, 2026, Addus HomeCare Corporation (ADUS) trades at a price-to-earnings ratio of 21.9x, with a stock price of $114.24 and trailing twelve-month earnings per share of $5.70.
The current P/E is 20% below its 5-year average of 27.5x. Over the past five years, ADUS's P/E has ranged from a low of 17.3x to a high of 34.9x, placing the current valuation at the 15th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.0x, ADUS is roughly in line with its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 174.5x.
The PEG ratio of 1.09 (P/E divided by 23% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, ADUS trades roughly in line with the S&P 500 median P/E of 25.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ADUS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ADUS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ADUS P/E vs Peers
Home-based care services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 26.6Lowest | - | +53%Best | |
| $10B | 30.2 | 2.19Best | +14% | |
| $1B | 46.9 | 4.66 | +18% | |
| $339B | 28.2 | - | -15% | |
| $111B | 62.7 | - | -62% | |
| $45B | 37.8 | - | -1% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ADUS Historical P/E Data (2009–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $100.47 | $5.70 | 17.6x | -37% |
| FY2026 Q1 | - | $93.65 | $5.41 | 17.3x | -38% |
| FY2025 Q4 | Dec 31 2025 | $107.39 | $5.21 | 20.6x | -26% |
| FY2025 Q3 | - | $117.99 | $4.67 | 25.3x | -9% |
| FY2025 Q2 | Jun 30 2025 | $115.19 | $4.53 | 25.4x | -9% |
| FY2025 Q1 | Mar 31 2025 | $98.89 | $4.43 | 22.3x | -20% |
| FY2024 Q4 | - | $125.35 | $4.24 | 29.6x | +6% |
| FY2024 Q3 | Sep 30 2024 | $133.03 | $4.37 | 30.4x | +9% |
| FY2024 Q2 | Jun 30 2024 | $116.11 | $4.22 | 27.5x | -1% |
| FY2024 Q1 | Mar 31 2024 | $103.34 | $4.03 | 25.6x | -8% |
| FY2023 Q4 | Dec 31 2023 | $92.85 | $3.84 | 24.2x | -13% |
| FY2023 Q3 | Sep 30 2023 | $85.19 | $3.55 | 24.0x | -14% |
| FY2023 Q2 | Jun 30 2023 | $92.70 | $3.31 | 28.0x | +1% |
| FY2023 Q1 | Mar 31 2023 | $106.76 | $3.10 | 34.4x | +24% |
| FY2022 Q4 | Dec 31 2022 | $99.49 | $2.85 | 34.9x | +25% |
| FY2022 Q3 | Sep 30 2022 | $95.24 | $2.75 | 34.6x | +24% |
| FY2022 Q2 | - | $83.28 | $2.76 | 30.2x | +8% |
| FY2022 Q1 | - | $93.29 | $2.78 | 33.6x | +21% |
| FY2021 Q4 | Dec 31 2021 | $93.51 | $2.80 | 33.4x | +20% |
| FY2021 Q3 | - | $79.75 | $2.52 | 31.6x | +14% |
| FY2021 Q2 | Jun 30 2021 | $87.24 | $2.37 | 36.8x | +32% |
| FY2021 Q1 | Mar 31 2021 | $104.59 | $2.08 | 50.3x | +81% |
| FY2020 Q4 | - | $117.09 | $2.07 | 56.6x | +103% |
| FY2020 Q3 | Sep 30 2020 | $94.51 | $2.17 | 43.6x | +57% |
| FY2020 Q2 | - | $92.56 | $1.91 | 48.5x | +74% |
| FY2020 Q1 | - | $67.60 | $1.89 | 35.8x | +29% |
| FY2019 Q4 | - | $97.22 | $1.71 | 56.9x | +104% |
| FY2019 Q3 | Sep 30 2019 | $79.28 | $1.44 | 55.1x | +98% |
| FY2019 Q2 | Jun 30 2019 | $74.95 | $1.40 | 53.5x | +92% |
| FY2019 Q1 | Mar 31 2019 | $63.59 | $1.35 | 47.1x | +69% |
| FY2018 Q4 | Dec 31 2018 | $67.88 | $1.41 | 48.1x | +73% |
| FY2018 Q3 | Sep 30 2018 | $70.15 | $1.33 | 52.7x | +90% |
| FY2018 Q2 | Jun 30 2018 | $57.25 | $1.35 | 42.4x | +52% |
| FY2018 Q1 | Mar 31 2018 | $48.65 | $1.22 | 39.9x | +43% |
| FY2017 Q4 | Dec 31 2017 | $34.80 | $1.17 | 29.7x | +7% |
| FY2017 Q3 | Sep 30 2017 | $35.30 | $1.55 | 22.8x | -18% |
| FY2017 Q2 | Jun 30 2017 | $37.20 | $1.41 | 26.4x | -5% |
| FY2017 Q1 | Mar 31 2017 | $32.00 | $1.41 | 22.7x | -18% |
| FY2016 Q4 | Dec 31 2016 | $35.05 | $1.05 | 33.4x | +20% |
| FY2016 Q3 | Sep 30 2016 | $26.16 | $0.68 | 38.5x | +38% |
| FY2016 Q2 | - | $17.43 | $0.79 | 22.1x | -21% |
| FY2016 Q1 | - | $17.19 | $0.85 | 20.2x | -27% |
| FY2015 Q4 | - | $23.28 | $1.03 | 22.6x | -19% |
| FY2015 Q3 | Sep 30 2015 | $31.15 | $1.09 | 28.6x | +3% |
| FY2015 Q2 | - | $27.86 | $1.12 | 24.9x | -11% |
| FY2015 Q1 | - | $23.02 | $1.23 | 18.7x | -33% |
| FY2014 Q4 | Dec 31 2014 | $24.27 | $1.25 | 19.4x | -30% |
| FY2014 Q3 | - | $19.60 | $0.98 | 20.0x | -28% |
| FY2014 Q2 | Jun 30 2014 | $22.48 | $0.92 | 24.4x | -12% |
| FY2014 Q1 | Mar 31 2014 | $23.05 | $0.74 | 31.1x | +12% |
| FY2013 Q4 | - | $22.45 | $1.76 | 12.8x | -54% |
| FY2013 Q3 | Sep 30 2013 | $28.97 | $2.03 | 14.3x | -49% |
| FY2013 Q2 | Jun 30 2013 | $19.74 | $1.96 | 10.1x | -64% |
| FY2013 Q1 | Mar 31 2013 | $13.19 | $1.88 | 7.0x | -75% |
| FY2012 Q4 | Dec 31 2012 | $7.15 | $0.71 | 10.1x | -64% |
| FY2012 Q3 | Sep 30 2012 | $5.35 | $0.81 | 6.6x | -76% |
| FY2011 Q2 | - | $5.43 | $0.48 | 11.3x | -59% |
| FY2011 Q1 | - | $5.01 | $0.52 | 9.6x | -65% |
| FY2010 Q4 | Dec 31 2010 | $4.10 | $0.57 | 7.2x | -74% |
| FY2010 Q3 | - | $3.97 | $0.26 | 15.3x | -45% |
| FY2010 Q2 | Jun 30 2010 | $5.98 | $0.52 | 11.5x | -59% |
| FY2010 Q1 | Mar 31 2010 | $6.04 | $0.73 | 8.3x | -70% |
| FY2009 Q4 | - | $9.20 | $1.58 | 5.8x | -79% |
Average P/E for displayed period: 27.8x
ADUS Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
17+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ADUS — Frequently Asked Questions
Quick answers to the most common questions about buying ADUS stock.
What is ADUS's P/E ratio?
Addus HomeCare Corporation (ADUS) trailing twelve-month P/E ratio is 21.9x, based on TTM diluted EPS of $5.70. The 5-year average P/E is 27.5x and the historical range spans 17.3x to 34.9x.
Is ADUS stock overvalued or undervalued?
ADUS trades at 21.9x P/E, below its 5-year average of 27.5x. At the 15th percentile of its historical range (17.3x–34.9x), the stock is priced at a discount to its own history.
Is ADUS stock expensive?
No, ADUS is not expensive on a historical basis. The current P/E of 21.9x is below the 5-year average of 27.5x and sits at the 15th percentile of its valuation range.
What is ADUS's historical P/E range?
Over the past 5 years, ADUS's P/E ratio has ranged from 17.3x to 34.9x, with a median of 28.0x and an average of 27.5x. The current P/E of 21.9x places the stock at the 15th percentile of this range. Full historical data spans 2009–2026.
How does ADUS's P/E compare to the S&P 500?
ADUS trades at 21.9x P/E versus the S&P 500 median of 25.5x. The 14% discount to the market suggests lower growth expectations or perceived higher risk.
How does ADUS's valuation compare to Healthcare peers?
Addus HomeCare Corporation P/E of 21.9x compares to the Healthcare sector median of 24.0x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ADUS's PEG ratio?
ADUS PEG ratio is 1.09, based on a P/E of 21.9x and EPS growth of 23.2%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is ADUS's earnings yield?
ADUS earnings yield is 4.56%, the inverse of its 21.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.